THE VONWILLEBRAND-FACTOR GENE AND GENETICS OF VONWILLEBRANDS DISEASE

被引:19
作者
GINSBURG, D [1 ]
机构
[1] UNIV MICHIGAN, SCH MED, HOWARD HUGHES MED INST, ANN ARBOR, MI 48104 USA
关键词
D O I
10.1016/S0025-6196(12)62393-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The von Willebrand factor (vWF) gene spans 178 kilobases in the human genome, is interrupted by 51 introns, and has been localized to human chromosome 12p12 --> 12pter. In addition, a pseudogene that duplicates the midportion of the vWF gene has been identified on chromosome 22. In several families, large vWF gene deletions have been identified as the basis for von Willebrand's disease (vWD). In most patients, however, the vWF gene is found to be grossly intact by Southern blot analysis, a result that implies a more subtle molecular defect. The advent of the polymerase chain reaction has allowed a more direct analysis in this group of patients. By this approach, missense mutations, all clustered within the same small region in the midportion of the vWF molecule, have been identified in several patients with type IIA vWD. Expression of mutant vWF by transfection into COS cells suggests that the characteristic loss of high-molecular-weight multimers seen in type IIA vWD many occur through at least two distinct mechanisms. In preliminary studies of of nondeletional type III vWD, a family has been identified with decreased vWF as a result of failure of production of messenger RNA from the affected vWF allele. This disorder could be due to defects in vWF gene transcription, RNA processing, or stability. As additional defects are identified, the accurate diagnosis of vWD at the molecular level may eventually become possible.
引用
收藏
页码:506 / 515
页数:10
相关论文
共 30 条
[1]  
BAHOU WF, 1988, BLOOD, V72, P308
[2]   EPITOPE MAPPING OF THE VONWILLEBRAND-FACTOR SUBUNIT DISTINGUISHES FRAGMENTS PRESENT IN NORMAL AND TYPE-IIA VONWILLEBRAND DISEASE FROM THOSE GENERATED BY PLASMIN [J].
BERKOWITZ, SD ;
DENT, J ;
ROBERTS, J ;
FUJIMURA, Y ;
PLOW, EF ;
TITANI, K ;
RUGGERI, ZM ;
ZIMMERMAN, TS .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (02) :524-531
[3]  
BERNARDI F, 1990, BLOOD, V75, P677
[4]   THE HUMAN VONWILLEBRAND-FACTOR GENE - STRUCTURE OF THE 5' REGION [J].
BONTHRON, D ;
ORKIN, SH .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 171 (1-2) :51-57
[5]   STRUCTURE OF PRE-PRO-VON WILLEBRAND FACTOR AND ITS EXPRESSION IN HETEROLOGOUS CELLS [J].
BONTHRON, DT ;
HANDIN, RI ;
KAUFMAN, RJ ;
WASLEY, LC ;
ORR, EC ;
MITSOCK, LM ;
EWENSTEIN, B ;
LOSCALZO, J ;
GINSBURG, D ;
ORKIN, SH .
NATURE, 1986, 324 (6094) :270-273
[6]  
CHANG HY, 1989, BLOOD S, V74, pA131
[7]   SEQUENCE-ANALYSIS OF ALPHA-1(VI) AND ALPHA-2(VI) CHAINS OF HUMAN TYPE-VI COLLAGEN REVEALS INTERNAL TRIPLICATION OF GLOBULAR DOMAINS SIMILAR TO THE A-DOMAINS OF VONWILLEBRAND-FACTOR AND 2 ALPHA-2(VI) CHAIN VARIANTS THAT DIFFER IN THE CARBOXY TERMINUS [J].
CHU, ML ;
PAN, TC ;
CONWAY, D ;
KUO, HJ ;
GLANVILLE, RW ;
TIMPL, R ;
MANN, K ;
DEUTZMANN, R .
EMBO JOURNAL, 1989, 8 (07) :1939-1946
[8]   MOLECULAR-CLONING OF THE HUMAN-GENE FOR VONWILLEBRAND-FACTOR AND IDENTIFICATION OF THE TRANSCRIPTION INITIATION SITE [J].
COLLINS, CJ ;
UNDERDAHL, JP ;
LEVENE, RB ;
RAVERA, CP ;
MORIN, MJ ;
DOMBALAGIAN, MJ ;
RICCA, G ;
LIVINGSTON, DM ;
LYNCH, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (13) :4393-4397
[9]  
EWENSTEIN BM, 1989, CLIN RES, V37, pA544
[10]   PROPOLYPEPTIDE OF VONWILLEBRAND-FACTOR CIRCULATES IN BLOOD AND IS IDENTICAL TO VONWILLEBRAND ANTIGEN-II [J].
FAY, PJ ;
KAWAI, Y ;
WAGNER, DD ;
GINSBURG, D ;
BONTHRON, D ;
OHLSSONWILHELM, BM ;
CHAVIN, SI ;
ABRAHAM, GN ;
HANDIN, RI ;
ORKIN, SH ;
MONTGOMERY, RR ;
MARDER, VJ .
SCIENCE, 1986, 232 (4753) :995-998